SEC Tracker
Get the app

Entero Therapeutics GRDX

A wholly-owned subsidiary of Entero Therapautics, Inc., ImmunogenX, LLC

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Signs a material agreement (1.01)
  • Takes on a new financial obligation (2.03)
  • Sets a director nomination date (5.08)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Entero Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 4931 and related industry codes: the same peer list as the financial tables.

  1. OPAL Fuels OPAL public float $65M, Jun 30, 2025
  2. Aedis Energy ADIS public float $2M, Jun 30, 2025
  3. Genie Energy GNE public float $512M, Jun 30, 2025
  4. Unitil UTL public float $833M, Jun 30, 2025
  5. Ocean Thermal Energy CPWR public float $181K, Jun 30, 2025